Martin W. Schoen, MD, MPH

Saint Louis University (SLU)

Dr. Martin Schoen is a hematologist/oncologist and hospitalist at St. Louis Veterans Affairs Medical Center and Assistant Professor of Medicine at Saint Louis University. He conducts research into health outcomes and disparities in cancer treatments using national VA data to the focus on comparative effectiveness of treatments and personalized medicine based on patient comorbidities. His current focus is understanding the survival, treatment duration, and adverse events of oral anti-androgens in the treatment of metastatic prostate cancer and has also worked identify risk factors for infections in chronic lymphocytic leukemia and thrombosis in multiple myeloma.

Dr. Schoen has been active in clinical trials focused on improving treatment of COVID-19 in patients admitted to the hospital. He was a site PI for the international ATTACC trial of anticoagulation in hospitalized patients with COVID-19 and the HITCH trial of using hormonal manipulation to decrease severity of COVID-19 in male veterans.